Bristol Myers Squibb

Bristol Myers Squibb (Nasdaq/NYSE: BMY) is a Pharmaceuticals company operating within the Health Care sector of the US equity market.

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

The company reports trailing twelve-month revenue of $11.49B and net income of $2.68B.

Key metrics include a return on equity of 13.3%, a debt-to-equity ratio of 3.31.

Use FINOTAUR to track BMY's price action, review fundamentals, and stay current with company news — all in one research dashboard.